Key Findings

⏰ Timing Is Everything for Ketamine PTSD Treatment

Scientists discovered that when you give S-ketamine after trauma makes a huge difference for PTSD outcomes. Early administration (day 1 after trauma) significantly improved PTSD symptoms, especially fear extinction, while late administration (day 7) was much less effective. The key mechanism involves dopamine neurons in the brain's reward center - these neurons' activity drops after trauma but gets restored by early ketamine intervention, helping replace traumatic memories during fear extinction.

🔬 MDA Shows Stronger But Harsher Effects Than MDMA

In a controlled trial with 23 healthy participants, researchers directly compared MDMA and MDA (its metabolite) at equal doses. MDA produced longer-lasting effects (6.1 hours vs 4.1 hours for MDMA) and stronger subjective experiences, but came with more negative side effects including greater fear, visual alterations, and 'bad drug effects.' A slow-release version (Lys-MDA) successfully delayed onset and peak effects, while the MDMA version (Lys-MDMA) failed to work entirely.

🧠 Psychedelics Could Help Restore Lost Brain Connections in Schizophrenia

New brain imaging technology revealed that people with schizophrenia have measurably lower synaptic density in their prefrontal cortex - the brain region crucial for executive function. This synaptic loss, caused by overactive immune cells pruning too many connections, could potentially be countered by psychedelics' proven ability to promote new synapse formation. The theory suggests microdosing psychedelics might restore brain connectivity and improve the negative symptoms that current medications struggle to address.

🎯 Psilocybin Decision Aid Helps Patients Navigate Treatment Choices

Researchers developed the first decision aid specifically for patients considering psilocybin-assisted therapy for existential distress. After testing with 5 patients and 5 healthcare professionals, the booklet-format tool covers treatment education, option comparisons, and personal reflection exercises. The tool met international standards for patient decision aids and received positive feedback for clarifying content and providing balanced information about this emerging treatment option.

⚠️ Psychedelic-Opioid Mix Creates Dangerous Breathing Problems

Testing in 6 rhesus monkeys revealed that combining the psychedelic DOM with fentanyl made breathing depression significantly worse than fentanyl alone. While DOM by itself didn't affect breathing, when mixed with fentanyl it amplified the dangerous respiratory effects that cause opioid overdoses. This finding raises important safety concerns as psychedelic use becomes more common and people may unknowingly combine substances.

🌟 Awe Experiences Strengthen Group Identity and Collective Action

Across five studies with 1,124 participants, researchers found that experiencing awe consistently strengthened 'identity fusion' - the strongest form of group connection where personal and group identities merge. The effect worked through awe's ability to make people feel small relative to something vast, creating readiness to bond deeply with groups. This held true across different awe triggers (memory recall, virtual reality) and various group types (country, university, community, nature).